Using a special desktop camera, AEYE takes images from each eye and through artificial intelligence it captures and analyzes data of the retina that helps diagnose diseases, including diabetes, that could lead to blindness.
https://www.pharmalive.com/wp-content/uploads/2022/09/ReutersFDA9-8-2022.jpg8001200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-11-15 09:06:052022-11-15 09:39:48AEYE Health gets FDA approval to screen diabetics to prevent blindness
